Evaluation of CSf-tau and CSF-AB42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice
Arch Neurol 58:373-379,349, Andreasen,N.,et al, 2001
Longitudinal Study of CSF Levels of Tau, A beta 1-40, and A beta 1-42 (43) in Alzheimer's Disease
Ann Neurol 44:17-26, 61998., Kanai,M.,et al, 1998
Apolipoprotein E, Dementia, and Cortical Deposition of B-Amyloid Protein
NEJM 333:1242-1247, 12831995., Polvikoski,T.,et al, 1995
Amyloidoma of the CNS. I. Clinical and Pathologic Study
Neurol 42:2019-2023, Cohen,M.,et al, 1992
Computed Tomographic Features of Nonthyroid Extraocular Muscle Enlargement
Ophthalmol 96:1038-1047, Patrinely,J.R.,et al, 1989
Dialysis Myelopathy:Quardiparesis Due to Extradural Amyloid of B2 Microglobulin Origin
BMJ 296:752-753, Allain,T.J.,et al, 1988
Familial Oculoleptomeningeal Amyloidosis, Report of a New Family with Unusual Features
Arch Neurol 45:1118-1122, Uitti,R.J.,et al, 1988
Brain Amyloid and Alzheimer Disease
Ann Int Med 109:41-54, Vinters,H.V.,et al, 1988